Clinical trial Recruiting at 1 site Observational Ages 60 to 80

Predicting nerve damage in patients with diabetes and chronic kidney disease

Official title: Estimate the Risk of Diabetic and Uremic Peripheral Neuropathy Using Physical and Functional Testing

Run by Université catholique de l'Ouest · NCT06933108 · Data updated 2026-11-12

This study is trying to see if better tests can help find nerve damage earlier in people with diabetes and chronic kidney disease.

More Diabetes trials

Quick facts

Study typeObservational
Ages60 Years to 80 Years
SexAll
Enrollment70 (estimated)
SponsorUniversité catholique de l'Ouest
Academic / other
Locations1 site (Le Mans)
StatusRecruiting
StartedJanuary 27, 2025
Main results expectedMay 2, 2025
Study endsMay 2, 2025
Registry record updatedApril 18, 2025
Trial IDNCT06933108 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with CKD stage 4-5 or diabetes who can walk 20 meters and have a BMI under 35.

Probably not a fit

Patients currently on dialysis, with cognitive impairments, or those with significant musculoskeletal or neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the risk of peripheral neuropathy in patients with chronic kidney disease (CKD) stages 3 and 4, as well as those with diabetes. It focuses on identifying the common complication of peripheral neuropathy, which affects a significant portion of these patients. The study will utilize functional testing methods to improve the accuracy of neuropathy screening, addressing the limitations of current diagnostic tests that are often subjective or only detect advanced stages of nerve damage.

Why it matters

Potential benefit: If successful, this study could lead to improved early detection and management of peripheral neuropathy in patients with diabetes and CKD.

How similar studies have gone: While the approach of using functional testing for neuropathy prediction is promising, it has not been extensively tested in similar studies, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* CKD stage 4-5 and / or diabetes (Type I or II)
* Able to walk 20 m
* BMI \< 35

Exclusion Criteria:

* Currently or planning dialysis
* Musculoskeletal, osteorarticular and neurological disease(s)
* Cognitive impairment
* Low-limb amputation

Where it's running

  • Centre Hospitalier Le Mans
    Le Mans, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.